Demand For Monoclonal Antibody Treatment Surges Across The Country

3
>>Follow Matzav On Whatsapp!<<

The demand for monoclonal antibody therapies to treat COVID-19 cases has risen dramatically in America in recent weeks as cases soar. Former President Donald Trump received an antibody cocktail manufactured by Regeneron Pharmaceuticals when he was infected with the virus, but the treatment didn’t become popular until now.

Part of the reason is that the therapy is given intravenously, and a single dose costs $1,250, according to NPR. So, even if the drug is distributed free of charge, the infusion alone can cost $1,000, which may result in hefty copayments even for people who are insured.

According to Axios, some states with low vaccination rates and sparse COVID-19 mitigation measures to stem the transmission of the virus have made these treatments more accessible. Texas and Florida have both opened state-funded infusion sites.

Regeneron is shipping 125,000 doses per week, up from 25,000 doses in mid-July. Half the medication is being sent to Florida, Texas, Mississippi, and Alabama, says Axios. Experts say that monoclonal antibody treatments may significantly reduce the risk of severe illness when used within a week of infection.

An analysis published in Open Forum Infectious Diseases found that the risk of hospitalization was 31% less in high-risk patients who received the infusions. This means that the antibodies can prevent one hospitalization in eight patients.

Read more at NEWSMAX.

{Matzav.com}


3 COMMENTS

  1. “…President Donald Trump received an antibody cocktail manufactured by Regeneron Pharmaceuticals when he was infected with the virus, but the treatment didn’t become popular until now.”

    Actually, Rabbi Hoffman wrote about this months ago in the Jewish media, and there were also ads for it in the Jewish media by an organization that started up with the purpose of spreading the word about this.

    In certain areas, though, it was limited to the elderly and others with risk factors.

    The main reason it “didn’t become popular until now”, though, is likely that the financial gain in marketing the vaccines is, presumably, much greater than this.

  2. Take more vaxes until you’ll become anti body. That’s the truth about the “anti body” baloney they’re convincing the gullible.

LEAVE A REPLY

Please enter your comment!
Please enter your name here